Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Any info about Iomega (IOM)? -- Ignore unavailable to you. Want to Upgrade?

To: Michael Coley who wrote (51227)	3/25/1998 7:42:00 PM
From: Glenn D. Rudolph	Read Replies (1) \| Respond to of 58324

IOM: BUCKINGHAM RES decreased estimate for fiscal year ending 12/98 from $0.50 to $0.15 on 03/20/98 IOM: BUCKINGHAM RES decreased estimate for fiscal year ending 12/99 from $0.70 to $0.40 on 03/20/98 IOM: BUCKINGHAM RES decreased estimate for quarter ending 03/98 from $0.09 to $-0.06 on 03/20/98 IOM: BUCKINGHAM RES decreased estimate for quarter ending 06/98 from $0.11 to $0.00 on 03/20/98 IOM: BUCKINGHAM RES decreased estimate for quarter ending 09/98 from $0.13 to $0.07 on 03/20/98 IOM: BUCKINGHAM RES decreased estimate for quarter ending 12/98 from $0.17 to $0.13 on 03/20/98

To: Michael Coley who wrote (51227)	3/25/1998 7:46:00 PM
From: Linda Pearson	Read Replies (1) \| Respond to of 58324

Michael, <I'm pretty sure that it wasn't just a freudian slip, but I'm surprised that nobody caught the missing letter in Linda's message (#reply-3826499). Linda, 20 pints in 2 1/2 gallons, isn't it?> LOL... OOOPS!!! Linda

To: Michael Coley who wrote (51227)	3/25/1998 8:01:00 PM
From: Zakrosian	Read Replies (1) \| Respond to of 58324

Michael - what a pleasure to see your post. The thread has turned absolutely ugly; and to compound the problem, the newer negative posters have little or nothing of value to contribute (unlike Rocky and Ken, who at least provided food for thought). I hope that you, Allan, jwk, Bill Lin and others continue to contribute your thoughts. At the moment it's kinda hard to see the positives - other than the fact that Iomega is still selling about a billion or so dollars worth of product a year. Much less than most optimists had hoped, but their diminished monthly sales are about equal to Syquest's annual revenues. What I do find troublesome is this: if they have been taking advantage of their dominant market position to try to extract premium pricing for their products, why have their margins remained at the 6-7% level?